Back to overview

RhoGTPase/Rho-kinase pathway as therapeutic target for treatment of human vascular disease. (MHV-Beitrag)

Applicant Ming Xiu-Fen
Number 63170
Funding scheme Marie Heim-Voegtlin grants
Research institution Département de Médecine Université de Fribourg
Institution of higher education University of Fribourg - FR
Main discipline Cardiovascular Research
Start/End 01.10.2000 - 30.09.2001
Approved amount 94'984.00
Show all

Responsible applicant and co-applicants